Aberrant motility and invasive ability are relevant hallmarks of malignant tumor cells. Pathways regulating the movement of cancer cells from the site of primary tumor toward adjacent and/or distant tissues are not entirely defined. By using a model of malignant transformation induced by Ras, we identified Wnt4 as an early target of Ras oncogenic signaling. Here we show that Wnt4 is repressed by Ras and that forced Wnt4 expression inhibits Ras-induced cell motility. Accordingly, we found that Wnt4 is downregulated in human anaplastic thyroid carcinomas, the most malignant and metastatic thyroid cancer histotype. Wnt4 interferes with Ras-induced actin cytoskeleton reorganization through non-canonical pathways, by altering the balance between the activation of different Rho-family small guanosine triphosphatases (GTPases). Finally, we demonstrate that Wnt4 is posttranscriptionally repressed by miR-24, a Ras-induced micro RNA (miRNA) targeting the 3 0 -untranslated region (UTR) of Wnt4. Taken together our data highlight a novel Ras-regulated miRNA-dependent circuitry regulating the motile phenotype of cancer cells.
INTRODUCTION
The ability of tumor cells to invade adjacent tissues and to metastatize to distant organs, acquired during the development of most human tumors, is considered one of the hallmarks of cancer, 1 marking the boundary between benign and malignant tumors. Invasion and metastatic dissemination are complex processes, involving alterations in cell shape and in cell-to-cell and cell-toextracellular matrix interactions. Development of distant metastases is the cause of 90% of human cancer deaths. Nevertheless, because of the complexity of the phenomenon, its genetic and biochemical determinants remain incompletely understood.
Thyroid carcinomas are broadly divided into well-differentiated, poorly differentiated and undifferentiated hystotypes. Welldifferentiated thyroid carcinomas include papillary and follicular types, which in most cases behave in an indolent manner and have an excellent prognosis. By contrast, undifferentiated or anaplastic thyroid carcinomas are highly aggressive and lethal tumors. The growth is very rapid and is associated with the invasion of adjacent tissues and metastatization. There is currently no effective treatment and death usually occurs within 1 year from diagnosis. The morphology and behavior of poorly differentiated thyroid carcinomas lies between those of well-differentiated and undifferentiated ones. The different histotypes are characterized by distinct arrays of genetic alterations that mainly activate a common effector pathway, involving the RET-Ras-BRAF signaling cascade. Unlike other solid neoplasms, however, Ras is mutated only in a small fraction of thyroid cancers. In papillary carcinomas, representing the most frequent histotype, Ras mutations are hardly detected, while in follicular, poorly differentiated and anaplastic carcinomas mutations in Ras genes are more frequently found 2 (COSMIC database, http://www.sanger.ac.uk/genetics/CGP/ cosmic/). Thus, Ras activation is likely to be involved mainly in late steps of thyroid tumor progression.
Ras is a monomeric guanosine triphosphate (GTP)-binding protein that has a key role in signal transduction as a molecular switch cycling between an active GTP-bound and an inactive guanosine diphosphate (GDP)-bound state. 3 A variety of effector proteins regulating different signaling pathways interact with active Ras, including Raf kinases and phosphatidylinositol 3-kinase. 3, 4 Other Ras effectors include guanine nucleotide exchange factors and GTPase-activating proteins coupling Ras to GTPases of the Ral or Rho family. 4 Rho-family members, including Rho, Rac and Cdc42, have been shown to be downstream effectors of Ras. 5 Through the activation of different effectors Ras regulates multiple biological processes like cell proliferation, apoptosis, cell differentiation, cell adhesion and motility. Raf/MEK/ERK kinases cascade is mainly involved in cell proliferation and differentiation control 6 while PI3K/Pdk/Akt pathway is involved in survival and apoptosis. 7, 8 Rho-family GTPases are instead preferentially involved in the regulation of cytoskeleton reorganization, cell motility and cell adhesion. Rho regulates formation of actin stress fibers and focal adhesions, Rac regulates membrane ruffling and lamellipodia formation, while Cdc42 is involved in filopodia formation. Rac activation is linked to the disruption of cadherin-mediated cell-cell adhesions and destabilization of adherens junctions, thus enhancing motility in Ras transformation of epithelial cells. 9, 10 Conversely, it has been shown that RhoA inhibition is necessary for spreading and migration of adherent cells. 11 Cell motility ultimately depends on the dynamic and antagonistic balance of Rac and Rho activation, thus alterations in such reciprocal control may lead to the aberrantly motile behavior of aggressive cancer cells. 12 We have previously shown that the expression of Ras oncogenes in normal rat thyroid cells (FRTL-5) is able to drive cell transformation toward an undifferentiated phenotype, resembling that of anaplastic carcinomas. 13, 14 In these cells pleiotropic effects of Ras include uncontrolled proliferation, complete loss of differentiation and acquisition of a migratory and invasive phenotype. In the present study we show that Ras downregulates the expression of Wnt4, a Wnt-family member known to be involved in migratory phenomena during development. [15] [16] [17] [18] Wnt ligands can signal through the canonical, b-catenin-mediated pathway, as well as through other noncanonical b-catenin-independent pathways, the planar cell polarity (PCP) and the Wnt-calcium (Wnt-Ca 2 þ ) pathways. b-catenin-dependent and -independent Wnt pathways regulate different aspects of cell behavior during cancer development. The PCP pathway leads to activation of Rho-family GTPases, thus regulating mainly cell motility and adhesion. It has been noted that the activation of canonical or PCP pathways is somewhat exclusive. How PCP and canonical signaling affect each other is currently under investigation.
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Wnt4 is classified as a non-canonical Wnt even though it has been demonstrated that, depending on the cellular context, Wnt4 is able to activate both canonical and non-canonical signaling.
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Wnt4 is mainly expressed in epithelial cells, and its expression is altered in several cancers. In highly invasive squamous carcinoma cells Wnt4 is strongly downregulated when compared with normal oral keratinocytes, being involved in the alteration of cell adhesion, cell motility and invasion associated with epithelial to mesenchymal transition during late steps of carcinogenesis. 21 Also in endometrial carcinomas Wnt4 is frequently downregulated.
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There are also cancers in which Wnt4 is overexpressed suggesting that it can exert different roles depending on the cellular context. 6, [23] [24] [25] Here we identify Wnt4 as a key player in Ras-mediated transformation of rat thyroid epithelial cells, being involved in the inhibition of aberrant motility of neoplastic cells. Our data indicate that such effect of Wnt4 is exerted through the activation of a non-canonical signaling involving Rho-family GTPases. We also show that Wnt4 is strongly downregulated in human anaplastic carcinomas thus suggesting that Wnt4 could be involved in advanced human thyroid cancer. The mechanism of Wnt4 repression by Ras involves the upregulation of miR-24, which, in turn, downregulates its target Wnt4. Taken together our data suggest that Wnt4 downregulation could be necessary for the progression of thyroid epithelial tumors toward a fully malignant phenotype.
RESULTS
Cell Motility of Ras-transformed FRTL-5 cells. FRTL-5 cells are well characterized normal rat thyroid epithelial cells, 26 extensively used to study the molecular mechanisms of neoplastic transformation in vitro. We investigated the ability of oncogenic Ras to promote cell motility by using FRTL-5ER-Ras V12 (FER1), a Ras-dependent tamoxifen-inducible FRTL-5-derived cell line. 13 The ability of FER1 cells to migrate in response to Ras induction was tested by scratch-wound assay. After 24 h of treatment the wound area was evidently smaller in FER1 cells treated with 4-hydroxy-tamoxifen (4OHT) respect to untreated cells (Figure 1a ). This indicates an early induction of cell motility by Ras. The increased motility of Ras-transformed cells was confirmed by transwell migration assay (Figure 1b) . Wound closure and transwell migration were unaffected by 4OHT in parental FRTL-5 cells (Figures 1a and b) , thus showing that cell migration is promoted by Ras and it is not an effect of 4OHT per se. We then asked if the ability of oncogenic Ras to promote FRTL-5 cells motility was maintained in FRTL-5 cells constitutively expressing human H-Ras V12 . Figure 1c shows that four independent Rastransformed clones (FR1-FR4) display increased invasive ability respect to control cells. These results indicate that increased cell motility is induced by both acute and chronic oncogenic Ras expression. Figure S1) . Meanwhile, a modest activation of ER-Ras V12 chimera is already detectable in untreated cells (Supplementary Figure S2) , suggesting that it could be sufficient to downregulate Wnt4 expression in the absence of 4OHT. To rule out the possibility that Wnt4 repression could be an artifact of either the chimeric oncogene or Ras overexpression, we measured Wnt4 expression in FRTL-5 cell clones expressing different levels of H-Ras V12 . Wnt4 protein expression is undetectable in all clones, regardless of Ras expression levels ( Figure 2c ). To characterize the relationship between the activation of Ras signaling pathways and the expression of Wnt4, we analyzed the status of the mitogenactivated protein kinases (MAPK) and PI3K-Akt pathways in FER1, as well as in parental cells. We interfered MEK and PI3K activity using, respectively, U0126 and LY294002 chemical inhibitors, either in the presence or in the absence of 4OHT. Wnt4 expression, as well as ERK1/2 and Akt phosphorylation, was revealed by western blot (Figures 2d and e) . MEK inhibition causes increase of basal levels of Wnt4 expression in both parental and FER cells. It is noteworthy that MAPK inhibition leads Wnt4 expression in FER1 cells to levels similar to those observed in untreated FRTL-5 cells (Figure 2d ). This strongly supports the hypothesis that Wnt4 basal level is kept at low levels in FER1 by baseline ER-Ras signaling through MAPK. Moreover, U0126 treatment rescues Wnt4 expression in 4OHT-treated FER1 to levels comparable to those of untreated cells, despite the incomplete inhibition of ERK phosphorylation (Figure 2d ). PI3K inhibition instead reduces the expression of Wnt4 in parental FRTL-5 cells, while does not modify Wnt4 expression in 4OHT-treated FER cells (Figure 2e ). These results suggest that physiological levels of Wnt4 expression are maintained by the interplay between the negative effects of MAPK and the positive effects of PI3K pathways, while only MAPK pathway seems to be essential for Wnt4 downregulation by oncogenic Ras. These data highlight a close control of Wnt4 expression by Ras downstream pathways, and demonstrate that oncogenic Ras signaling downregulates Wnt4 both acutely and chronically.
Wnt4 is downregulated in anaplastic thyroid cancer We asked if the observed correlation between deregulation of Wnt4 and neoplastic transformation of FRTL-5 cells occurs also in Figure 3 ). Interestingly, 6/6 ATC samples displayed a robust and statistically significant reduction of Wnt4 mRNA (Figure 3) . Moreover, the median of both PTC and ATC are evidently lower than that of normal samples (Figure 3 ). These data highlight a trend of Wnt4 repression especially in highly malignant thyroid cancers, and thus strongly suggest a possible role of Wnt4 in human thyroid cancer progression.
Wnt4 downregulation is necessary for the induction of aberrant cell motility The downregulation of Wnt4 observed in both in vitro and in vivo thyroid neoplastic transformation prompted us to investigate the potential functional role of Wnt4 in such process. To obtain cells in which the activation of Ras is uncoupled from Wnt4 repression, we stably transfected a Wnt4-encoding vector in FER1 cells (FERW). Such cells are supposed to maintain Wnt4 expression even when ER-Ras V12 is induced by 4OHT. We first confirmed that both expression and secretion of ectopic Wnt4 were unaffected by oncogenic Ras expression (Figures 4a and b) . We thus analyzed FERW clones phenotype. Among the multiple effects of Ras on FER1 cells phenotype, 13 neither dedifferentiation nor thyroidstimulating hormone (TSH)-independent proliferation were affected by forced Wnt4 expression (Supplementary Figures S3  and S4 ). We measured cell motility of FERW clones by transwell migration assay. A noteworthy impairment of cell motility was detected in FERW clones treated with 4OHT (Figure 4c ). Accordingly, scratch-wound assay revealed that while FER1 cells after 24 h from the scratch have almost completely healed the wound, FERW1 cells display a severely reduced wound healing (Figure 4d) .
To check if FERW1 cells inability to migrate when treated with 4OHT was effectively due to ectopic Wnt4 expression we knocked down Wnt4 by RNA interference (Figure 4e ) and measured FERW1 cells motility by transwell assay. The results demonstrate that Wnt4 silencing is able to rescue Ras-induced cell motility (Figure 4f) .
Finally, we asked if Wnt4 ectopic expression could be able to revert the enhanced motility of chronically transformed cells. To this aim FR1 cells were stably transfected with a Wnt4-encoding vector (FRW clones) (Figure 5a ). We observed a significant impairment of the motility of FRW clones compared with FR1 by transwell assay, thus showing that Wnt4 re-expression is able to interfere with migration of chronically transformed cells (Figure 5b ).
These data suggest that Wnt4 downregulation is essential for Ras-induced cell motility.
Wnt4 interferes with Ras-directed cytoskeleton reorganization Wnt4 is classified as a non-canonical Wnt being able to activate b-catenin-independent pathways. Among these, the Rho-family GTPases are the ones mostly involved in cell motility control. To investigate the involvement of these GTPases in Wnt4 interference with Ras-induced cell motility, we analyzed the effects of Ras on Rac and Rho activation in the absence or in the presence of Wnt4. We measured active (GTP loaded) fraction of Rac or Rho through pulldown assays, in FER1 and FERW1 cells untreated and treated with 4OHT. Figure 6a shows that oncogenic Ras increases the levels of active Rac regardless of the presence of ectopic Wnt4. Figure 6b shows instead a marked decrease in Rho activation induced by Ras, while ectopic Wnt4 induces high basal levels of active Rho and blocks Ras-dependent Rho inhibition. Actin cytoskeleton organization of both FER1 and FERW1 cells was analyzed by confocal microscopy. Actin-based structures were revealed by phalloidin staining while localization of focal adhesions was achieved by fluorescent staining of paxillin. Actin organization and paxillin localization are similar in untreated FER1 and FERW1 cells, thus showing that Wnt4 expression by itself does not affect cytoskeleton organization (Figure 6c ). Oncogenic Ras activation induces cortical actin reorganization promoting the formation of motile structures known as membrane ruffles in FER1 cells (Figure 6c ), accordingly to its ability to induce Rac (Figure 6a) . In Wnt4-expressing cells (FERW1) Ras activation does not elicit membrane ruffles formation, leading instead to actin assembly in stress fibers and re-localization of paxillin in adhesion plaques. These data highlight that Wnt4 is able to inhibit the negative regulation of Rho activity by Ras, thus inducing dramatic alterations in actin organization. The actin switch from ruffles to stress fibers, together with the formation of many adhesion plaques could be responsible for increased cell adhesion to the substrate, thus inducing the observed reduction in Ras-induced cell motility in the presence of Wnt4.
Mechanisms of Wnt4 repression by Ras
We have previously identified several micro RNAs (miRNAs) regulated by oncogenic Ras in FER1 cells. 27 Among these miR-24, a putative Wnt4-targeting miRNA, is strongly upregulated. Wnt4 expression in human thyroid cancer. Wnt4 expression was measured by quantitative real-time PCR in 21 PTC and six anaplastic thyroid carcinomas. RNA from three normal thyroids was used as control. Quantitative real-time PCR was carried in triplicate as described in Materials and methods. Glyceraldehyde 3-phosphate dehydrogenase was used as reference gene; results are reported as 2 À DCt . Two tail, unpaired student t-test was performed on both PTC and ATC carcinomas. Only Wnt4 downregulation observed in anaplastic thyroid carcinomas is statistically significant with a 0.047 P-value score (*). The bold line (-) represents the median values for each set of samples: normal thyroid, PTC and ATC samples.
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The opposite regulation of Wnt4 and miR-24 by Ras allowed us to hypothesize that miR-24 could mediate Wnt4 deregulation by Ras. We first confirmed that both acute and chronic oncogenic Ras expression were able to upregulate miR-24 ( Figure 7a ). As we have shown that MAPK activation is necessary for Wnt4 downregulation, we asked if also miR-24 induction is dependent on the same pathway. Treatment of FER1 cells with 4OHT in the presence of Mek inhibitor U0126 revealed that the upregulation of miR-24 by Ras is almost completely abolished when MAPK pathway was inhibited (Figure 7b ), strongly suggesting that miR-24 induction could have a role in Wnt4 repression. We then showed that transient expression of ectopic miR-24 in FRTL-5 cells causes a significant reduction of endogenous Wnt4 both at mRNA and protein level (Figures 7c and d) . To validate Wnt4 as a direct miR-24 target, we cloned a 420 bp fragment of Wnt4 3 0 UTR containing the miR-24 putative target site downstream to a luciferase reporter gene (Luc-Wnt4UTR) and compared the expression of Luc-Wnt4UTR with that of pGL3 control vector both in normal FRTL-5 cells and in FR1 cells, expressing high levels of endogenous miR-24. The results show that the presence of the Wnt4 3 0 -UTR exerts an inhibitory effect on the expression of luciferase much stronger in FR1 respect to FRTL-5 cells (Figure 7e) . Furthermore, the co-transfection of pre-miR-24 leads to a twofold downregulation of Luc-Wnt4UTR activity in normal FRTL-5 cells (Figure 7f ). Finally, we generated reporter vectors containing three tandem repeats of the predicted miR-24 target sequence in the 3 0 -UTR of Wnt4, either wildtype or mutated in its seed (LucWnt4 and Luc-mtWnt4, respectively). Both reporter vectors were transfected in FRTL-5 cells, together with pre-miR-24. The results highlight that miR-24 is able to repress the luciferase activity of Luc-Wnt4 reporter while it is not acting on Luc-mtWnt4 (Figure 7g ). These data strongly suggest that miR-24 is a key player in Wnt4 downregulation by Ras. However, miR-24 show highly variable expression levels in ATC (Supplementary Figure S5) , suggesting that additional mechanisms could be involved in Wnt4 repression in vivo.
To rule out the possibility that Ras represses Wnt4 also at the transcriptional level, we performed a RNA polymerase II (PolII) based chromatin immunoprecipitation. 28 The assay shows that RNA PolII occupancy of Wnt4-encoding sequences is 
DISCUSSION
The present study highlights for the first time a role for Wnt4 as a negative regulator of oncogene-induced cell motility in neoplastic transformation. We also show that Wnt4 is downregulated by Ras through a miRNA-dependent circuitry.
Wnt4 is a member of the Wnt family of glycoprotein signaling molecules known mostly for the roles they have in embryonic development. Deregulation of Wnt signaling is associated with many human diseases, particularly cancers.
Knockout mice indicate that Wnt4 regulates several phenotypes, including mesenchymal to epithelial transition and cell migration, in mammalian organogenesis. In developing kidney Wnt4 is necessary for mesenchymal to epithelial transition of metanephric mesenchyme leading to tubulogenesis. 15, 17, 18 Moreover, Wnt4 is expressed in both XX and XY developing gonads. After sex determination (at E11.5 in mouse) the malespecific repression of Wnt4 is necessary to allow the migration of endothelial and steroidogenic cells into the XY gonads. 29 Mechanisms underlying the regulation of Wnt4 expression during development are complex and have not been defined in their molecular details.
We show here that Wnt4 is rapidly repressed by the oncogenic activity of Ras, both at mRNA and at protein level. Chronically Rastransformed cells show repression of Wnt4 expression as well. We explored how Wnt4 expression is regulated by the two major Ras downstream signalings: MAPK and PI3K pathways. The baseline expression of Wnt4 in normal FRTL-5 cells is increased by MEK inhibition and repressed by PI3K inhibition. Accordingly to what happens in normal cells, in Ras-transformed cells MEK inhibition leads to the rescue of Wnt4 expression, while PI3K inhibition does not modify Wnt4 expression. Taken together our results indicate that the MAPK pathway acts as a negative regulator of Wnt4 expression in both normal and transformed cells, while the PI3K pathway is likely to be a positive regulator of physiologic Wnt4 expression. These data are in agreement with observations obtained in other normal thyroid cell systems showing that PI3K pathway cooperates with thyroid-stimulating hormone in thyroid differentiation maintenance, while the activation of MAPK exerts a de-differentiating effect (reviewed in Roger et al. 30 ). Wnt4 repression has already been reported in other cancers. Indeed it has been shown that in several endometrial carcinoma cell lines Wnt4 is expressed at very low levels compared with normal endometrial cells and in human endometrial carcinomas as well Wnt4 is strongly downregulated compared with normal tissue. 22 Furthermore, in highly invasive squamous carcinoma cells Wnt4 is strongly downregulated when compared with normal oral keratinocytes. In this latter case, it has been suggested that the combined overexpression of Wnt5a and downregulation of Wnt4 observed in these tumors could be involved in the alteration of cell adhesion, cell motility and invasion associated with epithelial to mesenchymal transition during late step of carcinogenesis. 21 Instead, Wnt4 overexpression has been detected in benign tumors, such as breast fibroadenomas and pituitary adenomas. [23] [24] [25] Accordingly, our analysis of human thyroid cancer biopsies reveals that Wnt4 is mainly repressed in anaplastic carcinomas, the most advanced and invasive histotype of thyroid cancer. It is noteworthy that all the anaplastic carcinomas analyzed display very low Wnt4 levels, while the differentiated thyroid cancers of the papillary histotype show wide variability in Wnt4 expression levels. Thus, we can speculate that Wnt4 repression could be a common event in thyroid epithelial carcinogenesis, particularly correlated with highly malignant cancers. Further analyses on a larger number of human samples, as well as functional studies in vivo are necessary to test this hypothesis.
We demonstrate here that forced expression of Wnt4, in the presence of oncogenic Ras activity, exerts an inhibitory effect on the motility of transformed cells. Thus, our data indicate that Wnt4 repression is necessary for Ras-induced thyroid cell motility. Furthermore, the proposed inhibitory role on cancer cell motility is consistent with the function played by Wnt4 in gonads and kidney development.
Wnt4 is able to activate either canonical or non-canonical pathways depending on the cell type. Interestingly, a recent paper shows that Wnt4 induces mesenchymal-to-epithelial transition leading to tubulogenesis in metanephric mesenchyme by a noncanonical mechanism. 18 Here we show that acute expression of oncogenic Ras, besides the repression of Wnt4, induces Rac activation, membrane ruffling and Rho inhibition. Ectopic Wnt4 signals through the PCP pathway, by inducing Rho activation in the absence of Ras activity. Interestingly, when both oncogenic Ras and Wnt4 are expressed, Wnt4 impairs Ras-induced Rho Wnt4 inhibits Ras-induced cell motility M De Menna et al inhibition. The observed Rho activation by Wnt4 correlates with a dramatic switch in actin cytoskeleton reorganization characterized by stress fibers and focal adhesions. The differences in cytoskeleton organization in the presence of Wnt4 are consistent with the impairment of Ras-transformed cells motility. Indeed, it has been shown that increased stress fibers and focal adhesions formation is correlated with reduced cell motility in different cell types. Murine embryonic fibroblasts null for all Ras genes show severely impaired cell migration, associated with actin stress fibers and dramatic increase in focal adhesions with reduced dynamics. 31 Furthermore, overexpression of the docking protein Gab2 in mammary epithelial cells leads to enhanced cell migration associated to a decrease in stress fibers and focal adhesions. In these cells, Gab2 inhibits RhoA activation while concomitant expression of constitutively active RhoA restores stress fibers and focal adhesions, indicating that RhoA inhibition is necessary for suppressing these structures and enhancing cell motility. 32 We can thus speculate that the dramatic increase in stress fibers and focal adhesion observed in the presence of Wnt4 could be responsible for increased cell adhesion with consequent cell motility impairment.
Finally, here we highlight a post-transcriptional layer of regulation of Wnt4 expression. We previously demonstrated that Ras is able to affect multiple miRNAs expression. 14, 27 Here we show that cell motility is regulated by Ras through a miRNAdependent circuitry. Indeed we validated Wnt4 as a direct target of miR-24, a Ras-induced miRNA, leading us to propose that miR-24 mediates Ras-induced Wnt4 suppression. miR-24 has been found overexpressed in several cancers, including breast, prostate and lung cancer. [33] [34] [35] [36] It has also been demonstrated that miR-24 participates to an epigenetic feedback loop initiating and sustaining hepatocyte transformation. 37 Intriguingly, a recent paper shows that miR-24 participates in epithelial to mesenchymal transition by targeting Net1A, a RhoA-specific guanine nucleotide exchange factor, thus causing inhibition of RhoA and increase of cancer cell invasiveness. 38 Remarkably, our data suggest that miR-24 can similarly exert a Rho-inhibitory effect through the repression of Wnt4, thus adding another important piece to the puzzle of miRNAs function in cancer progression.
In conclusion, we show that Wnt4 repression by Ras is necessary to allow aberrant cell migration in vitro and propose that its downregulation in human anaplastic thyroid carcinomas could contribute to the malignant phenotype of thyroid cancer.
MATERIALS AND METHODS
FRTL-5 cells and their derivatives were propagated as described. 13 Expression vectors and reporter vectors were transfected using FuGene 6 (Roche Applied Science, Penzberg, Germany). Firefly and Renilla luciferase activity were assayed, respectively, with the Luciferase Assay activates Rho, thus inhibiting Ras-induced cell motility through the enhancement of stress fibers and focal adhesions. The question mark (?) close to the connection line between Ras and Rho points out that Rho inhibition could be due to either a Wnt4-dependent mechanism or a completely unrelated mechanism, or a combination of both.
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